Tuberculosis

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)

1. 1. Investing in Health
   1. Annex 1.A: The Burden of Disease in 2001
2. 2. Intervention Cost–Effectiveness: Overview of Main Messages
   1. Discussion
3. 4. Priorities for Global Research and Development of Interventions
4. 5. Science and Technology for Disease Control: Past, Present, and Future
5. 6. Product Development Priorities
   1. Diagnostics
   2. Financing and Institutional Arrangements for New Product Development
   3. Intellectual Property
   4. Introduction
6. 8. Improving the Health of Populations: Lessons of Experience
   1. Cases
7. 9. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?
   1. Costing and Financing Additional Spending for the MDGs
8. 11. Fiscal Policies for Health Promotion and Disease Prevention
   1. Subsidies for Health and Health-Related Products
   2. Taxes and Tax Expenditures: Design and Outcomes
   3. Use of Fiscal Policy for Health in Developing Countries
9. 13. Recent Trends and Innovations in Development Assistance for Health
   1. Conclusions
   2. Making Development Assistance for Health More Effective: Lessons Learned
   3. Recent Innovations to Improve the Effectiveness of Development Assistance for Health
10. 16. Tuberculosis
    1. Acknowledgments
    2. Alternative and Complementary Approaches to the Diagnosis and Treatment of Active Disease
    3. Conclusions
    4. Cost-Effectiveness of Interventions against Tuberculosis
    5. Cost-Effectiveness of Managing Endemic Tuberculosis
    6. Cost-Effectiveness of Managing Tuberculosis Outbreaks
    7. Epidemiological Burden and Trends
    8. Interventions against Tuberculosis
    9. Research and Development
    10. Summary of Cost-Effectiveness Analyses
    11. Tuberculosis Infection, Disease, and Death
11. 20. Vaccine–Preventable Diseases
    1. Improving the Costs and Cost-Effectiveness of Immunization Programs
12. 35. Respiratory Diseases of Adults
    1. Acute Diseases: Pneumonia and Influenza
    2. Chronic Respiratory Diseases: Nature, Causes, and Burden
    3. Future Research Needs
    4. General Approach to Lowering Risk of Adult Respiratory Disease
    5. Occupational Lung Disease and Other Respiratory Diseases
13. 42. Indoor Air Pollution
    1. Conclusions
    2. Nature, Causes, and Burden of Condition
14. 55. Drug Resistance
    1. Agenda for Action
    2. Implementation of Strategies: Two Lessons from Experience
    3. Interventions
    4. Risk Factors
15. 60. Occupational Health
    1. Economic Aspects of Intervention
    2. Global Burden of Disease from Occupational Health Risks
    3. Nature and Causes of Occupational Health Conditions in the Developing World
16. 64. General Primary Care
    1. Scaling Up
    2. The Effectiveness of General Primary Care
17. 65. The District Hospital
    1. The Future: Research and Information Needs
18. 72. Ensuring Supplies of Appropriate Drugs and Vaccines
    1. Issues for the Future
    2. Procurement of Drugs
    3. Selection of Drugs
    4. Storage and Distribution of Essential Drugs and Vaccines
    5. The WHO Prequalification Schemes
    6. Vaccine Research Priorities

Global Burden of Disease and Risk Factors

1. 2. Demographic and Epidemiological Characteristics of Major Regions, 1990—2001
2. 3. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001
   1. Burden of Disability and Poor Health in 2001
   2. Discussion and Conclusions

Priorities in Health

1. 1. Accomplishments, Challenges, and Priorities
2. 2. Success in Addressing Priorities
3. 4. Cost–Effective Strategies for the Excess Burden of Disease in Developing Countries
4. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
   1. Alcohol Abuse
   2. Cancer
   3. Tobacco Use
5. 6. Providing Interventions
   1. Levels of Care
6. 7. Pillars of the Health System
   1. Financing
   2. Human Resources
   3. Management of Health Services

Chapter Presentations

Chapter 02. Intervention Cost-Effectiveness: Overview of Main Messages

1. Cost-effectiveness of Interventions for Epidemic Tuberculosis in Low- and Middle-Income Countries
2. Cost-effectiveness of Interventions for Endemic Tuberculosis in Low- and Middle-Income Countries
3. Neglected Low-Cost Opportunities in South Asia: HIV/AIDS and Tuberculosis

Chapter 06. Product Development Priorities

1. Product Development for HIV/AIDS and TB, Public-Private Partnerships, 2004

Chapter 09. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?

1. Effective Interventions to Achieve the Tuberculosis MDG